Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response

Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response

US Patent 9782474 · Granted Oct 10, 2017

Estimated economic value: $1,191,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antigen screening system2021
Treatment methods2020
Vaccines against herpes simplex virus type 2: compositions and methods for elici2020
Vaccines against herpes simplex virus type 2: compositions and methods for elici2020
Vaccines against herpes simplex virus type 2: compositions and methods for elici2020
Antigen screening system2020
Vaccines against herpes simplex virus type 2: compositions and methods for elici2018
Vaccines against herpes simplex virus type 2: compositions and methods for elici2018
Vaccines against herpes simplex virus type 2: compositions and methods for elici2018
Antigen screening system2018
Fused antigen vaccines and compositions against Streptococcus pneumoniae2017
Nucleic acid vaccines against herpes simplex virus type 2: compositions and meth2017